Basel 6 May 2020:As part of its strategy to lead in the area of implant immediacy, the Straumann Group has announced a new zygomatic implant solution that it will bring to market in collaboration with Southern Implants. The new solution combines proven implant design features with the advantages of Straumann’s BLX and BLT implant prosthetic range for fixed overdentures. The new system comprises two designs – to cater for differences in bone availability and morphology – and can be used with the Straumann CARES digital workflow to plan the implant position by computer. It will be sold exclusively by Straumann and is currently undergoing clinical evaluation in eight international centers prior to initial market release.

Centers of excellence to increase access to zygomatic treatment

Zygomatic procedures constitute a niche segment because the treatment is complex and requires specialist experience. For this reason, Straumann is working together with leading international surgeons to establish centers of excellence devoted to advancing techniques, sharing knowledge, enhancing skills, and training more specialists.

About zygomatic implants

Zygomatic implants have been used for several years and differ from conventional dental implants in that they are anchored in the zygomatic (cheek) bone rather than the maxilla (upper jaw). They are used in patients with insufficient bone in the posterior upper jaw, due for example to age, tumor resection, trauma, or atrophy. Because of the firm stability achievable in the dense bone of the zygomatic region, and the wide stress distribution achieved on these tilted implants, a prosthesis can often be placed immediately at the time of surgery.

Figure 1 Straumann® Zygomatic Implant System

About Southern Implants

Southern Implant has a long tradition in zygomatic implants spanning more than 20 years. The company is a leading provider of innovative dental implant products with a focus on top-end professional users who want more choices. Southern’s expertise in research, development and manufacturing of dental implants allows it to provide Innovative Treatment Solutions that will reduce treatment times and improve patient outcomes. The company was established in 1987 and is headquartered in South Africa. Its global network of professional representatives is dedicated and committed to provide high level technical support. The company aims to compliment clinicians’ ability to deliver exemplified standards of care to their patients and referral base.

About Straumann

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs approx. 7600 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.